Ranbaxy to sell Daiichi Sankyo product in Malaysia

Drug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo said on Wednesday Ranbaxy will market its parent company's products in Malaysia as part of their initiative to harness synergies between......

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

Drug major Sun Pharmaceutical on Wednesday said its promoter and managing director Dilip Shanghvi did not buy shares of the company sold by the Japanese drugmaker Daiichi Sankyo. ". . .Dilip......

Ranbaxy, Daiichi Sankyo to leverage synergies

Drug firm Ranbaxy Laboratories and its Japanese parent Daiichi Sankyo will integrate their business operations in Thailand as part of strategy to maximise synergies.Both the companies intend to......

Blackstone, Baring in race to acquire up to 20% stake in Cipla

In one of the largest potential transactions this year, private-equity majors Blackstone and Baring have initiated talks with the Hamied family, the promoters of pharmaceutical firm Cipla, to......